Affron (R) and increase in positive mood : evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
- Author
- Dominique Turck, Jacqueline Castenmiller, Stefaan De Henauw (UGent) , Karen Ildico Hirsch-Ernst, John Kearney, Helle Katrine Knutsen, Alexandre Maciuk, Inge Mangelsdorf, Harry J. McArdle, Androniki Naska, Carmen Pelaez, Kristina Pentieva, Frank Thies, Sophia Tsabouri, Marco Vinceti, Jean-Louis Bresson and Alfonso Siani
- Organization
- Abstract
- Following an application from Pharmactive Biotech Products, S.L. submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Spain, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to affron (R) and contributes to maintain a healthy mood. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is affron (R), an aqueous saffron extract with a content of the sum of crocins and safranal typically between 3.5% and 3.9%. The Panel notes that affron (R) is sufficiently characterised. The claimed effect proposed by the applicant is 'contributes to maintain a healthy mood'. The Panel notes that increase in positive mood is a beneficial physiological effect for individuals with low mood or anxiety. One human intervention study showed that consumption of affron (R) at a dose of 28 mg/day for 4 weeks improves mood in a population of adults with low mood. However, the results have not been replicated in other studies. The information supplied by the applicant did not provide evidence for a plausible mechanism by which affron (R) could exert the claimed effect. The Panel concludes that the evidence is insufficient to establish a cause and effect relationship between the consumption of affron (R) and increase in positive mood. (C) 2021 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.
- Keywords
- affron (R), saffron, crocins, safranal, mood, anxiety, health claim, CROCUS-SATIVUS-L., REVISED CHILD ANXIETY, CONSTITUENT CROCIN, SAFFRON, EXTRACT, DOUBLE-BLIND, STRESS, DEPRESSION, SYMPTOMS
Downloads
-
published.pdf
- full text (Published version)
- |
- open access
- |
- |
- 1.55 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01GW4DDQX5930VS4WEQC2W2CYA
- MLA
- Turck, Dominique, et al. “Affron (R) and Increase in Positive Mood : Evaluation of a Health Claim Pursuant to Article 13(5) of Regulation (EC) No 1924/2006.” EFSA JOURNAL, vol. 19, no. 7, European Food Safety Authority-EFSA, 2021, doi:10.2903/j.efsa.2021.6669.
- APA
- Turck, D., Castenmiller, J., De Henauw, S., Hirsch-Ernst, K. I., Kearney, J., Knutsen, H. K., … Siani, A. (2021). Affron (R) and increase in positive mood : evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA JOURNAL, 19(7). https://doi.org/10.2903/j.efsa.2021.6669
- Chicago author-date
- Turck, Dominique, Jacqueline Castenmiller, Stefaan De Henauw, Karen Ildico Hirsch-Ernst, John Kearney, Helle Katrine Knutsen, Alexandre Maciuk, et al. 2021. “Affron (R) and Increase in Positive Mood : Evaluation of a Health Claim Pursuant to Article 13(5) of Regulation (EC) No 1924/2006.” EFSA JOURNAL 19 (7). https://doi.org/10.2903/j.efsa.2021.6669.
- Chicago author-date (all authors)
- Turck, Dominique, Jacqueline Castenmiller, Stefaan De Henauw, Karen Ildico Hirsch-Ernst, John Kearney, Helle Katrine Knutsen, Alexandre Maciuk, Inge Mangelsdorf, Harry J. McArdle, Androniki Naska, Carmen Pelaez, Kristina Pentieva, Frank Thies, Sophia Tsabouri, Marco Vinceti, Jean-Louis Bresson, and Alfonso Siani. 2021. “Affron (R) and Increase in Positive Mood : Evaluation of a Health Claim Pursuant to Article 13(5) of Regulation (EC) No 1924/2006.” EFSA JOURNAL 19 (7). doi:10.2903/j.efsa.2021.6669.
- Vancouver
- 1.Turck D, Castenmiller J, De Henauw S, Hirsch-Ernst KI, Kearney J, Knutsen HK, et al. Affron (R) and increase in positive mood : evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA JOURNAL. 2021;19(7).
- IEEE
- [1]D. Turck et al., “Affron (R) and increase in positive mood : evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006,” EFSA JOURNAL, vol. 19, no. 7, 2021.
@article{01GW4DDQX5930VS4WEQC2W2CYA,
abstract = {{Following an application from Pharmactive Biotech Products, S.L. submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Spain, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to affron (R) and contributes to maintain a healthy mood. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is affron (R), an aqueous saffron extract with a content of the sum of crocins and safranal typically between 3.5% and 3.9%. The Panel notes that affron (R) is sufficiently characterised. The claimed effect proposed by the applicant is 'contributes to maintain a healthy mood'. The Panel notes that increase in positive mood is a beneficial physiological effect for individuals with low mood or anxiety. One human intervention study showed that consumption of affron (R) at a dose of 28 mg/day for 4 weeks improves mood in a population of adults with low mood. However, the results have not been replicated in other studies. The information supplied by the applicant did not provide evidence for a plausible mechanism by which affron (R) could exert the claimed effect. The Panel concludes that the evidence is insufficient to establish a cause and effect relationship between the consumption of affron (R) and increase in positive mood. (C) 2021 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.}},
articleno = {{6669}},
author = {{Turck, Dominique and Castenmiller, Jacqueline and De Henauw, Stefaan and Hirsch-Ernst, Karen Ildico and Kearney, John and Knutsen, Helle Katrine and Maciuk, Alexandre and Mangelsdorf, Inge and McArdle, Harry J. and Naska, Androniki and Pelaez, Carmen and Pentieva, Kristina and Thies, Frank and Tsabouri, Sophia and Vinceti, Marco and Bresson, Jean-Louis and Siani, Alfonso}},
issn = {{1831-4732}},
journal = {{EFSA JOURNAL}},
keywords = {{affron (R),saffron,crocins,safranal,mood,anxiety,health claim,CROCUS-SATIVUS-L.,REVISED CHILD ANXIETY,CONSTITUENT CROCIN,SAFFRON,EXTRACT,DOUBLE-BLIND,STRESS,DEPRESSION,SYMPTOMS}},
language = {{eng}},
number = {{7}},
pages = {{14}},
publisher = {{European Food Safety Authority-EFSA}},
title = {{Affron (R) and increase in positive mood : evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006}},
url = {{http://doi.org/10.2903/j.efsa.2021.6669}},
volume = {{19}},
year = {{2021}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: